Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1962 Jul;19(3):211–215. doi: 10.1136/oem.19.3.211

Oral Calcium Disodium Versenate in Treatment of Lead Poisoning

J D Williams 1,2,*, G A Matthews 1,2, A W Judd 1,2
PMCID: PMC1038198  PMID: 14007184

Abstract

A clinical trial of oral calcium disodium versenate (E.D.T.A.) in eight lead workers is described. A short course of versenate given while the men continued at work produced no side-effects. Complete overhaul of the processes and protective devices was made in the factory.

Clinical, biochemical, and haematological improvement followed the removal of up to 250 mg. lead in each case.

The mode of action and possible uses and abuses of oral versenate are discussed.

Full text

PDF
211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELL R. F., GILLILAND J. C., BOLAND J. R., SULLIVAN B. R. Effect of oral edathamil calcium-disodium on urinary and fecal lead excretion; comparative excretory studies with intravenous therapy. AMA Arch Ind Health. 1956 Apr;13(4):366–371. [PubMed] [Google Scholar]
  2. BRADLEY J. E., POWELL A. M., Jr Oral calcium EDTA in lead intoxication of children. J Pediatr. 1954 Sep;45(3):297–301. doi: 10.1016/s0022-3476(54)80193-4. [DOI] [PubMed] [Google Scholar]
  3. COTTER L. H. Treatment of lead poisoning by chelation. J Am Med Assoc. 1954 Jul 3;155(10):906–908. doi: 10.1001/jama.1954.73690280005007c. [DOI] [PubMed] [Google Scholar]
  4. FOREMAN H., TRUJILLO T. T. The metabolism of C14 labeled ethylenediaminetetraacetic acid in human beings. J Lab Clin Med. 1954 Apr;43(4):566–571. [PubMed] [Google Scholar]
  5. GILES H. M., MOORE C. J., STILL B. M. Treatment of lead poisoning with calcium disodium versenate. Lancet. 1955 Jan 22;268(6856):183–185. doi: 10.1016/s0140-6736(55)91910-3. [DOI] [PubMed] [Google Scholar]
  6. KEHOE R. A. Misuse of edathamil calciumdisodium for prophylaxis of lead poisoning. J Am Med Assoc. 1955 Jan 22;157(4):341–342. [PubMed] [Google Scholar]
  7. KING E., THOMPSON A. R. The measurement of lead absorption in industry. Ann Occup Hyg. 1961 Jun;3:247–263. [PubMed] [Google Scholar]
  8. LECKIE W. J., TOMPSETT S. L. The diagnostic and therapeutic use of edathamil calcium disodium (EDTA, versene) in excessive inorganic lead absorption. Q J Med. 1958 Jan;27(105):65–82. [PubMed] [Google Scholar]
  9. MANVILLE I. A., MOSER R. Recent developments in the care of workers exposed to lead; the effect of the calcium chelate of disodium ethylenediamine-tetraacetic acid on lead in the blood and urine of battery workers. AMA Arch Ind Health. 1955 Nov;12(5):528–538. [PubMed] [Google Scholar]
  10. MARKUS A. C., SPENCER A. G. Treatment of chronic lead-poisoning with calcium disodium versenate. Br Med J. 1955 Oct 8;2(4944):883–885. doi: 10.1136/bmj.2.4944.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SHIELS D. O., THOMAS D. L., KEARLEY E. Treatment of lead poisoning by edathamil calcium-disodium. AMA Arch Ind Health. 1956 May;13(5):489–498. [PubMed] [Google Scholar]
  12. SIDBURY J. B., Jr, BYNUM J. C., FETZ L. L. Effect of chelating agent on urinary lead excretion; comparison of oral and intravenous administration. Proc Soc Exp Biol Med. 1953 Feb;82(2):226–228. doi: 10.3181/00379727-82-20073. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES